U.S. Hospitality Stock News

NYSE:JKS
NYSE:JKSSemiconductor

Is JinkoSolar (JKS) Offering Value After Recent Share Price Volatility And Cash Flow Outlook

If you are wondering whether JinkoSolar Holding’s current share price gives you good value, this article will walk through what the numbers actually say about the stock. The share price closed at US$25.81 most recently, with returns of 1.4% over the past week, a 1.9% decline over the past month, a 7.6% decline year to date, and a 30.8% gain over the last year, while the 3 year and 5 year returns are 45.1% and 50.4% declines respectively. Recent interest in solar and semiconductor related...
NasdaqGS:NDAQ
NasdaqGS:NDAQCapital Markets

Nasdaq (NDAQ) Margin Jump To 21.8% Tests High Valuation Narratives

NasdaqGS:NDAQ just closed out FY 2025 with fourth quarter revenue of US$2.1b and basic EPS of US$0.18, alongside trailing twelve month revenue of US$8.2b and EPS of US$1.56 that frame the full year picture. The company has seen revenue move from US$7.4b to US$8.2b over the latest trailing periods, with trailing EPS shifting from US$1.94 to US$1.56. This gives investors a clear read on how the top line and per share earnings have tracked into this result. With net profit margin running at...
NasdaqGS:TOWN
NasdaqGS:TOWNBanks

TowneBank (TOWN) Net Interest Margin Gain Tests Bullish Earnings Narratives

TowneBank (TOWN) has wrapped up FY 2025 with fourth quarter total revenue of US$220.1 million and basic EPS of US$0.52, alongside trailing twelve month revenue of US$811.8 million and EPS of US$2.22, setting the tone for how you might read the latest print. Over the past few quarters, total revenue has moved from US$175.6 million in Q4 2024 to US$220.1 million in Q4 2025, while quarterly EPS shifted from US$0.55 to US$0.52. These figures now sit against a trailing twelve month net income of...
NYSE:KOS
NYSE:KOSOil and Gas

Is Kosmos Energy’s (KOS) Tender Offer Extension Reframing Its Balance Sheet Strategy or Just Tinkering?

Kosmos Energy recently extended, in the past, the early tender and withdrawal deadlines for its cash offer to repurchase up to US$250 million of its 7.750% Senior Notes due 2027, giving bondholders more time to participate while still receiving total consideration. This extension highlights Kosmos Energy’s ongoing liability management efforts, which could influence the timing and composition of its balance sheet and future financing flexibility. Next, we’ll examine how extending the senior...
NasdaqGS:DRH
NasdaqGS:DRHHotel and Resort REITs

A Look At DiamondRock Hospitality (DRH) Valuation After Fresh Optimism From Deutsche Bank And Morgan Stanley

Analyst sentiment puts DiamondRock Hospitality in focus Recent analyst moves at Deutsche Bank and Morgan Stanley have put DiamondRock Hospitality (DRH) back on investor radar, as both firms highlighted the hotel REIT’s positioning in what they view as resilient lodging markets. See our latest analysis for DiamondRock Hospitality. At a share price of US$9.19, DiamondRock’s recent moves tell a mixed story, with a 1 day share price return of 1.66% and a 7 day share price return of a 4.27%...
NYSE:FHI
NYSE:FHICapital Markets

Federated Hermes Hong Kong Move Puts Asia Growth And Valuation In Focus

Federated Hermes, NYSE:FHI, has received board approval to establish a new office in Hong Kong. The expansion is aimed at serving major financial institutions across Asia more directly. The move marks a material shift in the company’s geographic footprint beyond its existing bases. Federated Hermes, trading at $53.03, is extending its reach into Asia with a Hong Kong office aimed at deepening relationships with large financial institutions. The company has delivered a 37.4% return over the...
NasdaqGS:CCB
NasdaqGS:CCBBanks

Coastal Financial CEO Share Sale Spurs Fresh Look At Growth Versus Risks

Coastal Financial CEO executes an open market sale of company shares under a Rule 10b5-1 trading plan. The transaction involves pre arranged selling activity by an insider at NasdaqGS:CCB. The move attracts attention as investors review what it may signal about leadership and capital allocation. For context, Coastal Financial, trading on NasdaqGS:CCB, last closed at $100.81. The stock has seen a 12.1% gain over the past year, alongside very large returns over the past 5 years. More...
NYSE:FIG
NYSE:FIGSoftware

Is Figma (FIG) Pricing Still Justified After Recent 28% Slide In The Share Price

If you are wondering whether Figma's share price lines up with its real worth, this article will walk through what the numbers are actually saying about valuation. The stock last closed at US$27.07, with returns of a 4.8% decline over 7 days and a 28.1% decline over 30 days, which may have changed how some investors see its risk and potential reward. Recent coverage around Figma has focused on its position in collaborative design software and how investors are weighing that against the...
NYSE:HZO
NYSE:HZOSpecialty Retail

MarineMax (HZO) Q1 Loss Deepens YoY And Tests Turnaround Bullish Narratives

MarineMax (HZO) opened Q1 2026 with revenue of US$505.2 million and a basic EPS loss of US$0.36, compared with Q1 2025 revenue of US$468.5 million and EPS of US$0.80. Over the intervening quarters, revenue ranged between roughly US$552 million and US$657.2 million. EPS moved from a profit of US$0.15 in Q2 2025 to a larger loss of US$2.42 in Q3 2025, keeping margin pressure firmly in focus for investors trying to make sense of the latest print. See our full analysis for MarineMax. With the...
NasdaqGS:ABCL
NasdaqGS:ABCLLife Sciences

AbCellera Advances ABCL635 Menopause Candidate As Shares Trade Below Targets

AbCellera Biologics (NasdaqGS:ABCL) has begun dosing patients in the Phase 2 portion of its Phase 1/2 clinical trial for ABCL635. ABCL635 is a non hormonal candidate for treating moderate to severe vasomotor symptoms associated with menopause. This Phase 2 dosing milestone marks further clinical progress in the company's efforts to develop a potential first in class menopause therapy. AbCellera Biologics, known for its antibody discovery platform, is pushing deeper into clinical development...
NasdaqGS:TFSL
NasdaqGS:TFSLBanks

Can TFS Financial’s Margin and Cost Pressures Recast Its Profit Story for Investors in TFSL?

TFS Financial Corporation recently reported past first-quarter results for the period ended December 31, 2025, with net interest income rising to US$75.68 million while net income held roughly steady at US$22.27 million, or US$0.08 per share. Beneath the stable earnings per share, the company is contending with pressure on net interest margins and higher non-interest costs linked to bonuses, marketing, and technology spending, even as management points to strong capital and credit...
NYSE:WGO
NYSE:WGOAuto

Is Winnebago Industries (WGO) Pricing Too Rich After Its Recent 30% Monthly Jump

If you are wondering whether Winnebago Industries is a bargain or a value trap at around US$46.65 per share, this breakdown will help you frame that question with actual numbers. The stock is roughly flat over the last year with a 0.2% return. It shows a 13.4% gain over the past 30 days and a 3.8% decline over the last week, alongside longer term 3 year and 5 year returns of 25.8% and 25.4% declines. Recent moves in the share price sit against a backdrop of ongoing interest in RV and outdoor...
NasdaqGM:NRIX
NasdaqGM:NRIXBiotechs

Nurix Therapeutics (NRIX) Q4 Loss Highlights Ongoing Profitability Concerns Despite Revenue Progress

Nurix Therapeutics (NRIX) closed out FY 2025 with Q4 revenue of US$13.6 million and a basic EPS loss of US$0.82, while the trailing twelve months show revenue of US$84.0 million and a basic EPS loss of US$3.05. Over recent periods, the company has seen quarterly revenue range from US$7.9 million to US$44.1 million and basic EPS losses move between US$0.52 and US$1.03 per quarter. This sets the backdrop for what remains an early stage, loss making biotech story. For investors, the key question...
NasdaqGS:EXTR
NasdaqGS:EXTRCommunications

Is Extreme Networks (EXTR) Attractive After Recent Share Price Weakness?

Wondering whether Extreme Networks is priced attractively today or if the recent share moves are a warning sign? This article focuses squarely on what you are getting for the current price. The stock last closed at US$14.37, with returns of a 5.4% decline over the past week, a 14.9% decline over the last month, and a 13.1% decline year to date. The 1 year return is a 7.9% decline and the 3 year return is a 23.6% decline, compared with a 5 year return of 61.1%. Recent attention around Extreme...